Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Pα+ Psychedelic Bulletin #162: EQUULUS Therapeutics Emerges from Stealth; Responses to...

Decolonization, Difficult Conversations, and the Challenge of Merging Spirituality and Science

Insights from the European Medicines Agency’s Psychedelics Workshop: A Pα+ Dispatch

Self Awareness and Inner Work: Essential Skills for Psychedelic-Informed Practitioners

The Microdosing Effect: Connecting the Dots Between Anecdote and Evidence

Bicycle day Reflections, Quantum Mechanics, and the Value in Studying Philosophy...

Pα+ Psychedelic Bulletin #161: Numinus Shifts Focus to US; Algernon Makes...

Rethinking Drug Education: From D.A.R.E. Scare Tactics to an Evidence-Based Approach

Tracking Legal Psychedelics in the U.S. and Worldwide

1...232425...218 Page 24 of 218

From Huxley to Heffter: Mark Geyer Reflects on a Life in...

Advanced Shadow Work and Psychedelic Integration: A Jungian Path to Wholeness

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin

The Ketamine Conundrum